Nivolumab Plus Ipilimumab in Thyroid Cancer

Condition:   Thyroid Cancer
Interventions:   Drug: Nivolumab;   Drug: Ipilimumab
Sponsors:   Dana-Farber Cancer Institute;   Bristol-Myers Squibb
Not yet recruiting - verified August 2017

http://ift.tt/2uuJKPE